FDA Issues Letter to Health Care Providers Regarding Use of Passive Protective Barriers

Updated: Sep 10, 2020

The US Food and Drug Administration (FDA) had originally approved an Emergency Use Authorization on 1 May 2020 for passive protective barriers used primarily during intubation of patients. These barriers were to be utilized in addition to appropriate personal protective equipment (PPE). However, the FDA has now received preliminary evidence in simulated models that the barriers without negative pressure still expose health care providers. They may also, restrict the providers ability to intubate. Recommendations are to utilize the barrier with negative pressure and to utilize appropriate PPE. Lastly, the barrier should be removed if it becomes an obstacle to patient care. Please refer to: https://www.fda.gov/medical-devices/letters-health-care-providers/protective-barrier-enclosures-without-negative-pressure-used-during-covid-19-pandemic-may-increase

1 view0 comments

Recent Posts

See All

The Centers for Disease Control and Prevention National Safety Healthcare Network (CDC NHSN) published in January guidance for the Patient Safety Component Manual. Please check your specific areas to

Becton, Dickinson and Company have issued a voluntary recall of the 2Hi-Lite Orange™ 26 mL Applicator (2% w/w chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)) better known as ChloraP